Highland Capital Management (Tennessee)’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-23,937
Closed -$1.77M 348
2023
Q4
$1.77M Sell
23,937
-133
-0.6% -$8.72K 0.11% 183
2023
Q3
$1.64M Sell
24,070
-379
-2% -$32.2K 0.11% 183
2023
Q2
$2.3M Buy
+24,449
New +$1.91M 0.15% 162
2022
Q2
Sell
-20,023
Closed -$1.4M 331
2022
Q1
$1.4M Buy
20,023
+135
+0.7% +$9.87K 0.08% 210
2021
Q4
$1.55M Buy
+19,888
New +$1.76M 0.09% 215

Other funds holding EXAS

Highland Capital Management (Tennessee)'s EXAS Position: Q1 2024 in Review

Highland Capital Management (Tennessee) sold out of Exact Sciences (EXAS) in Q1 2024, closing a stake of 23,937 shares — an estimated $1.77M sold.

Highland Capital Management (Tennessee) first reported a position in EXAS in Q4 2021 and held it in 5 quarters. The position peaked at $2.3M in Q2 2023. 627 funds tracked by Wall St. Rank hold EXAS as of Q1 2024.

  • Highland Capital Management (Tennessee) reported no remaining Exact Sciences position as of Q1 2024 after selling out during the quarter.
  • Highland Capital Management (Tennessee) sold 23,937 Exact Sciences shares in Q1 2024, an estimated $1.77M.
  • Highland Capital Management (Tennessee) first reported a position in Exact Sciences in Q4 2021 and held it in 5 quarters.
  • Highland Capital Management (Tennessee)'s Exact Sciences position peaked at $2.3M in Q2 2023.
  • 627 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2024.

Based on Highland Capital Management (Tennessee)'s 13F filing for Q1 2024, filed 7 May 2024.